This record contains raw data related to article “Intrahepatic Cholangiocellular Carcinoma With Radiological Enhancement Patterns Mimicking Hepatocellular Carcinoma" Abstract Non-invasive diagnosis of hepatocellular carcinoma (HCC) in cirrhotic patients requires demonstration of wash-in and wash-out on contrast-enhanced imaging. Recent studies have reported misclassification of mass-forming intrahepatic cholangiocarcinoma (MFCCC) as HCC. We aimed to analyze the contrast enhancement patterns of MFCCC, focusing especially on lesions mimicking HCC. We retrospectively evaluated all consecutive patients with MFCCC who underwent surgery between 2007 and 2017. Patients with mixed HCC-MFCCC were excluded. Two expert radiologists reviewed preop...
I NTRODUCTION AND AIM: The American Association for the Study of the Liver (AASLD) recommends cont...
PurposeThe present study aimed to determine the reliable imaging features to distinguish atypical he...
In the setting of cirrhotic liver, the diagnosis of hepatocellular carcinoma (HCC) is straightforwar...
AIM: Primary aim was to validate the percentage of intrahepatic cholangiocarcinomas (ICC) which hav...
OBJECTIVE: Incidence of intrahepatic mass-forming cholangiocarcinoma (IMCC) is increasing worldwide,...
Aim: Primary aim was to validate the percentage of intrahepatic cholangiocarcinomas (ICC) which have...
Abstract Background Combined hepatocellular-cholangio...
Background & Aims: Contrast enhanced computed tomography (CT-scan) is a standard of care for the rad...
BACKGROUND & AIMS: Contrast enhanced computed tomography (CT-scan) is a standard of care for the rad...
PURPOSE: Liver transplant guidelines for diagnosing hepatocellular carcinoma (HCC) do not mandate pa...
none12noBackground: Diagnosis of hepatocellular carcinoma can be achieved by imaging in cirrhotic pa...
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary hepatic malignancy, with mas...
Hepatocellular carcinoma (HCC) is a unique malignancy that can be diagnosed and treated based on non...
Background: The diagnosis of intrahepatic cholangiocellular carcinoma (ICC) remains elusive at imagi...
Background: The diagnosis of intrahepatic cholangiocellular carcinoma (ICC) remains elusive at imagi...
I NTRODUCTION AND AIM: The American Association for the Study of the Liver (AASLD) recommends cont...
PurposeThe present study aimed to determine the reliable imaging features to distinguish atypical he...
In the setting of cirrhotic liver, the diagnosis of hepatocellular carcinoma (HCC) is straightforwar...
AIM: Primary aim was to validate the percentage of intrahepatic cholangiocarcinomas (ICC) which hav...
OBJECTIVE: Incidence of intrahepatic mass-forming cholangiocarcinoma (IMCC) is increasing worldwide,...
Aim: Primary aim was to validate the percentage of intrahepatic cholangiocarcinomas (ICC) which have...
Abstract Background Combined hepatocellular-cholangio...
Background & Aims: Contrast enhanced computed tomography (CT-scan) is a standard of care for the rad...
BACKGROUND & AIMS: Contrast enhanced computed tomography (CT-scan) is a standard of care for the rad...
PURPOSE: Liver transplant guidelines for diagnosing hepatocellular carcinoma (HCC) do not mandate pa...
none12noBackground: Diagnosis of hepatocellular carcinoma can be achieved by imaging in cirrhotic pa...
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary hepatic malignancy, with mas...
Hepatocellular carcinoma (HCC) is a unique malignancy that can be diagnosed and treated based on non...
Background: The diagnosis of intrahepatic cholangiocellular carcinoma (ICC) remains elusive at imagi...
Background: The diagnosis of intrahepatic cholangiocellular carcinoma (ICC) remains elusive at imagi...
I NTRODUCTION AND AIM: The American Association for the Study of the Liver (AASLD) recommends cont...
PurposeThe present study aimed to determine the reliable imaging features to distinguish atypical he...
In the setting of cirrhotic liver, the diagnosis of hepatocellular carcinoma (HCC) is straightforwar...